Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder

Scand J Urol. 2017 Feb;51(1):85-86. doi: 10.1080/21681805.2016.1271826. Epub 2017 Jan 13.

Abstract

Human papillomavirus (HPV) is an accepted causative agent in cervical cancer of the uterus, penile cancer, anal cancer and oropharyngeal carcinomas, while its role in other cancers such as urinary bladder cancer is still much discussed. This report presents a patient with multiple HPV types in a squamous cell carcinoma of the urinary bladder.

Keywords: Bladder cancer; human papillomavirus; squamous cell carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy
  • Carcinoma, Squamous Cell / virology*
  • Colostomy
  • Cystectomy
  • Female
  • Humans
  • Hysterectomy
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Neoplasms, Second Primary / complications
  • Neoplasms, Second Primary / pathology
  • Neoplasms, Second Primary / therapy
  • Neoplasms, Second Primary / virology*
  • Papillomaviridae / genetics
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / virology*
  • Pelvic Exenteration
  • Polymerase Chain Reaction
  • Radiotherapy, Adjuvant
  • Urinary Bladder Neoplasms / complications
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / therapy
  • Urinary Bladder Neoplasms / virology*
  • Urinary Diversion
  • Uterine Cervical Neoplasms / therapy
  • Uterine Cervical Neoplasms / virology*

Substances

  • Antineoplastic Agents